Epidemiology, molecular biology, diagnostic and therapeutic strategy of malignant pleural mesothelioma in 2007 - An update;Prise en charge dignostique et thérapeutique du mé sothéliome pleural malin en 2007

Revue des Maladies Respiratoires

Volumn 24, Issue 8 C2, 2007, Pages

  Porret, E ^a   Madelaine, J ^a,b   Galateau Salle F ^a,b   Bergot, E ^a,b   Zalcman, G ^a,b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Asbestos; Bevicizumab; Mesothelioma; Pemetrexed; Thoracoscopy

Indexed keywords

ASBESTOS; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; GEMCITABINE; MITOMYCIN; NAVELBINE; PEMETREXED; PLACEBO; PROTEIN P16; RALTITREXED; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SCATTER FACTOR RECEPTOR; VASCULOTROPIN; VINBLASTINE; WT1 PROTEIN;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOGENESIS; CELL DIVISION; CELL INVASION; CELL MOTILITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; GENE MUTATION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LUNG RESECTION; MALIGNANT MESOTHELIOMA; MOLECULAR BIOLOGY; MONOTHERAPY; MUTATOR GENE; NF2 GENE; OCCUPATIONAL EXPOSURE; OUTCOME ASSESSMENT; PATHOGENESIS; PLEURA BIOPSY; PLEURA MESOTHELIOMA; POSITRON EMISSION TOMOGRAPHY; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; THORACOSCOPY;

EID: 42649100954     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)